Objective: Adipocyte fatty acid-binding protein (A-FABP) is expressed in adipose tissue and macrophages. It regulates cholesterol trafficking and is involved in atherosclerosis formation. A-FABP levels are associated with cardiovascular diseases (CVDs) in patients with or without chronic kidney disease. In this study, we evaluated A-FABP levels in healthy controls and hemodialysis (HD) patients and compared the results with C-reactive protein (CRP) and interleukin-6 (IL-6) levels to determine their relationship with systemic inflammation
OBJECTIVE: Protein-energy wasting (PEW) and inflammation are common and related to increased cardiov...
Background: Cardiovascular disease is the leading cause of mortality in hemodialysis patients and is...
Abstract Objective: Diabetic nephropathy (DN) is one of the most common and severe consequences...
Objective: Adipocyte fatty acid-binding protein (A-FABP) is expressed in adipose tissue and macropha...
ObjectiveIncreased body mass index (BMI) is associated with reduced all-cause and cardiovascular (CV...
OBJECTIVE - To investigate the relationships of serum adipocyte fatty acid-binding protein (A-FABP) ...
Background: Fatty acid-binding protein 4 (FABP4/A-FABP/aP2), a lipid chaperone, is expressed in both...
BACKGROUND: Fatty acid-binding protein 4 (FABP4/A-FABP/aP2), a lipid chaperone, is expressed in both...
Fatty acid-binding protein 4 (FABP4/A-FABP/aP2), a lipid chaperone, is expressed in both adipocytes ...
Chronic inflammation is the cause of malnutrition and cardiovascular disease in hemodialysis patient...
Patients with end-stage renal disease (ESRD) include a significant percentage of malnourished patie...
Abstract Background Chronic kidney disease (CKD) is associated with cardiovascular events. Adipocyte...
PubMedID: 16257843Objective. Cardiovascular complications due to atherosclerosis (AS) are the major ...
Background: Inflammation has been associated with atherosclerotic cardiovascular disease (CVD) and a...
WOS: 000232883400009PubMed ID: 16257843Objective. Cardiovascular complications due to atherosclerosi...
OBJECTIVE: Protein-energy wasting (PEW) and inflammation are common and related to increased cardiov...
Background: Cardiovascular disease is the leading cause of mortality in hemodialysis patients and is...
Abstract Objective: Diabetic nephropathy (DN) is one of the most common and severe consequences...
Objective: Adipocyte fatty acid-binding protein (A-FABP) is expressed in adipose tissue and macropha...
ObjectiveIncreased body mass index (BMI) is associated with reduced all-cause and cardiovascular (CV...
OBJECTIVE - To investigate the relationships of serum adipocyte fatty acid-binding protein (A-FABP) ...
Background: Fatty acid-binding protein 4 (FABP4/A-FABP/aP2), a lipid chaperone, is expressed in both...
BACKGROUND: Fatty acid-binding protein 4 (FABP4/A-FABP/aP2), a lipid chaperone, is expressed in both...
Fatty acid-binding protein 4 (FABP4/A-FABP/aP2), a lipid chaperone, is expressed in both adipocytes ...
Chronic inflammation is the cause of malnutrition and cardiovascular disease in hemodialysis patient...
Patients with end-stage renal disease (ESRD) include a significant percentage of malnourished patie...
Abstract Background Chronic kidney disease (CKD) is associated with cardiovascular events. Adipocyte...
PubMedID: 16257843Objective. Cardiovascular complications due to atherosclerosis (AS) are the major ...
Background: Inflammation has been associated with atherosclerotic cardiovascular disease (CVD) and a...
WOS: 000232883400009PubMed ID: 16257843Objective. Cardiovascular complications due to atherosclerosi...
OBJECTIVE: Protein-energy wasting (PEW) and inflammation are common and related to increased cardiov...
Background: Cardiovascular disease is the leading cause of mortality in hemodialysis patients and is...
Abstract Objective: Diabetic nephropathy (DN) is one of the most common and severe consequences...